Premenstrual Syndrome, Premenstrual Dysphoric Disorder, and Beyond: A Clinical Primer for Practitioners
- 1 October 2004
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 104 (4), 845-859
- https://doi.org/10.1097/01.aog.0000140686.66212.1e
Abstract
The management of adverse premenstrual symptoms has presented a difficult challenge for clinicians. However, based on numerous well-designed research studies over the last decade, we now have diagnostic criteria for the severe form of the syndrome, premenstrual dysphoric disorder, and a variety of evidence-based therapeutic strategies. This review presents a comprehensive, practical description of what the clinician needs to know to diagnose and treat adverse premenstrual symptoms at all levels of severity. Diagnostic criteria are described in detail, including a discussion of the distinction between premenstrual dysphoric disorder and premenstrual syndrome (PMS). The rationale for including prospective symptom calendars as a routine part of the diagnostic evaluation of severe symptoms is presented. The differential diagnosis of cyclic symptoms, including depression and anxiety disorders, menstrual migraine, and mastalgia, and an approach for the management of each of these problems are presented. A treatment approach is recommended that matches the treatment to the degree of problems the woman is experiencing. Serotonin reuptake inhibitors are the treatment of choice for severe symptoms, and most women with PMS/premenstrual dysphoric disorder will respond to intermittent, luteal phase-only therapy. Ovulation suppression should be reserved for women who do not respond to other forms of therapy. The role of oophorectomy is limited, and guidelines for its use are presented.Keywords
This publication has 56 references indexed in Scilit:
- Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraineObstetrics & Gynecology, 2003
- Premenstrual Dysphoric DisorderThe New England Journal of Medicine, 2003
- Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine HeadacheAnnals of Internal Medicine, 2002
- Severity of premenstrual symptoms in a health maintenance organization populationObstetrics & Gynecology, 2002
- Concurrent Use of Oral Contraceptives With Antidepressants for Premenstrual SyndromesJournal of Clinical Psychopharmacology, 2001
- HORMONE-RELATED HEADACHEMedical Clinics of North America, 2001
- Migraine with aura and reproductive life events: a case control studyCephalalgia, 2000
- Is Premenstrual Dysphoric Disorder a Distinct Clinical Entity?Journal of Women's Health & Gender-Based Medicine, 1999
- MENSTRUATION, SEX HORMONES, AND MIGRAINENeurologic Clinics, 1997
- The Epidemiology and Social Impact of Premenstrual SymptomsClinical Obstetrics and Gynecology, 1987